Rohan Keshwara
Overview
Explore the profile of Rohan Keshwara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurup D, Fisher C, Scher G, Yankowski C, Testa A, Keshwara R, et al.
J Infect Dis
. 2021 Jan;
224(6):995-1004.
PMID: 33421072
Background: The objective of this study is to evaluate the immunogenicity of adjuvanted monovalent rabies virus (RABV)-based vaccine candidates against Ebola virus (FILORAB1), Sudan virus (FILORAB2), Marburg virus (FILORAB3), Lassa...
2.
Keshwara R, Shiels T, Postnikova E, Kurup D, Wirblich C, Johnson R, et al.
NPJ Vaccines
. 2019 May;
4:18.
PMID: 31098303
[This corrects the article DOI: 10.1038/s41541-019-0109-5.].
3.
Keshwara R, Shiels T, Postnikova E, Kurup D, Wirblich C, Johnson R, et al.
NPJ Vaccines
. 2019 Apr;
4:15.
PMID: 31016033
Nipah Virus (NiV) is a re-emerging zoonotic pathogen in the genus of the family of viruses. NiV is endemic to Bangladesh and Malaysia and is highly fatal to both livestock...
4.
Keshwara R, Hagen K, Abreu-Mota T, Papaneri A, Liu D, Wirblich C, et al.
J Virol
. 2018 Dec;
93(6).
PMID: 30567978
Marburg virus (MARV) is a filovirus related to Ebola virus (EBOV) associated with human hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality rate of upward of...
5.
Keshwara R, Johnson R, Schnell M
Annu Rev Med
. 2016 Oct;
68:371-386.
PMID: 27686015
Long-term control of viral outbreaks requires the use of vaccines to impart acquired resistance and ensuing protection. In the wake of an epidemic, established immunity against a particular disease can...
6.
Johnson R, Kurup D, Hagen K, Fisher C, Keshwara R, Papaneri A, et al.
J Infect Dis
. 2016 Jul;
214(suppl 3):S342-S354.
PMID: 27456709
The 2013-2016 West African Ebola virus (EBOV) disease outbreak was the largest filovirus outbreak to date. Over 28 000 suspected, probable, or confirmed cases have been reported, with a 53%...
7.
Willet M, Kurup D, Papaneri A, Wirblich C, Hooper J, Kwilas S, et al.
J Infect Dis
. 2015 Jun;
212 Suppl 2:S414-24.
PMID: 26063224
We previously described the generation of a novel Ebola virus (EBOV) vaccine based on inactivated rabies virus (RABV) containing EBOV glycoprotein (GP) incorporated in the RABV virion. Our results demonstrated...
8.
Shah V, Huang Y, Keshwara R, Ozment-Skelton T, Williams D, Keshvara L
J Immunol
. 2008 Feb;
180(5):2777-85.
PMID: 18292498
Microglia are the resident mononuclear phagocytic cells that are critical for innate and adaptive responses within the CNS. Like other immune cells, microglia recognize and are activated by various pathogen-associated...